<PAGE> 1
As filed with the Securities and Exchange Commission on May 10, 1999
Registration No. 333-77121
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
HEALTH MANAGEMENT SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
New York
(State or other jurisdiction of incorporation or organization)
13-2770433
(I.R.S. Employer Identification Number)
401 Park Avenue South, New York, New York 10016
(Address of Principal Executive Offices)
HEALTH MANAGEMENT SYSTEMS, INC.
1999 LONG-TERM INCENTIVE STOCK PLAN
(Full title of the Plan)
Paul J. Kerz, President
Health Management Systems, Inc.
401 Park Avenue South
New York, New York 10016
(Name and address of agent for service)
(212)685-4545
(Telephone number, including area code, of agent for service)
copies to:
Bruce S. Coleman, Esq.
Coleman, Rhine & Goodwin LLP
750 Lexington Avenue
New York, New York 10022
(212) 317-8880
<PAGE> 2
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 clarifies the language of the S-3
Reoffer Prospectus to indicate that the Prospectus may be utilized for
reofferings of Common Stock acquired by certain Potential Future Selling
Shareholders if they should exercise vested awards granted to them through
participation in the Plan. This Post-Effective Amendment No. 1 does not increase
the number of shares of Common Stock registered hereunder. This Post-Effective
Amendment No. 1 has been prepared in accordance with the requirements of Form
S-8 to register shares of Common Stock issuable pursuant to the Registrant's
1999 Long-Term Incentive Stock Plan (the "Plan"). The Plan was adopted by the
Registrant's shareholders upon the expiration of, and as a replacement for, the
Registrant's prior Stock Option and Restricted Stock- Purchase Plan. Under cover
of this Form S-8 is a Reoffer Prospectus prepared in accordance with the
requirements of Part I of Form S-3.
<PAGE> 3
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
Pursuant to Rule 428(b)(1) under the Securities Act of 1933, as amended
(the "Act"), an Information Statement with respect to the Health Management
Systems, Inc. 1999 Long-Term Incentive Stock Plan (the "Plan") will be
distributed to holders of stock options granted under such Plan. The Information
Statement, together with the documents incorporated by reference herein pursuant
to Item 3 of Part II below, taken together, constitute a Section 10(a)
prospectus and the Information Statement is hereby incorporated by reference in
this Registration Statement.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
There are hereby incorporated by reference herein the following
documents which have been filed with the Securities and Exchange Commission (the
"Commission"):
(a) the Registrant's Annual Report on Form 10-K for its fiscal year
ended October 31, 1998, filed with the Commission on January 11, 1999;
(b) the Registrant's Quarterly Report on Form 10-Q for the quarter
ended January 31, 1999, filed with the Commission on March 17, 1999;
(c) all other reports filed pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") since the end
of the Registrant's fiscal year ended October 31, 1998; and
(d) the description of the Registrant's Common Stock contained in the
Registrant's Form 8-A filed with the Commission.
All documents filed by the Registrant pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Exchange Act after the date of this Registration
Statement and prior to the filing of a post-effective amendment hereto that
indicate that all securities offered have been sold or that deregisters all such
securities then remaining unsold, shall be deemed to be incorporated by
reference herein and to be a part hereof from the date of filing of such
documents.
II-1
<PAGE> 4
Any statement contained in a document incorporated by reference herein
shall be deemed to be modified or superseded for purposes of this Registration
Statement to the extent that a statement contained herein or in any other
subsequently filed document that also is incorporated or deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration Statement.
ITEM 4. DESCRIPTION OF SECURITIES.
Not applicable.
ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.
Not applicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 722 of the New York Business Corporation Law (the "BCL")
provides that a corporation may indemnify directors and officers as well as
other employees and individuals against judgments, fines, amounts paid in
settlement and reasonable expenses, including attorneys' fees, in connection
with actions or proceedings, whether civil or criminal (other than an action by
or in the right of the corporation - a "derivative action"), if they acted in
good faith and in a manner they reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe their conduct was unlawful. A
similar standard is applicable in the case of derivative actions, except that
indemnification only extends to amounts paid in settlement and reasonable
expenses (including attorneys' fees) incurred in connection with the defense or
settlement of such actions, and the statute does not apply in respect of a
threatened action, or a pending action that is settled or otherwise disposed of,
and requires court approval before there can be any indemnification where the
person seeking indemnification has been found liable to the corporation. Section
721 of the BCL provides that Article 7 of the BCL is not exclusive of other
indemnification that may be granted by a corporation's certificate of
incorporation, disinterested director vote, stockholder vote, agreement or
otherwise. Article VIII, Section 7, of the Registrant's by-laws requires the
Registrant to indemnify its officers and directors to the fullest extent
permitted under the BCL.
II-2
<PAGE> 5
Any amendment to or repeal of the Registrant's certificate of
incorporation or by-laws shall not adversely affect any right or protection of a
director of the Registrant for or with respect to any acts or omissions of such
director occurring prior to such amendment or repeal.
ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.
Not applicable.
ITEM 8. EXHIBITS.
Exhibit
Number Description
+4 Health Management Systems, Inc. 1999 Long-Term Incentive Stock Plan.
+5 Opinion of Coleman, Rhine & Goodwin LLP with respect to the legality of
the securities being registered.
+23.1 Consent of Coleman, Rhine & Goodwin LLP (included in Exhibit 5).
23.2 Consent of KPMG LLP.
+24 Powers of Attorney.
- --------
+ Previously filed
ITEM 9. UNDERTAKINGS.
The undersigned Registrant hereby undertakes:
(a) to file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement to include any
material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such
information in the Registration Statement;
(b) that, for the purpose of determining any liability under the Act,
each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof; and
II-3
<PAGE> 6
(c) to remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of
the offering.
The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Act, each filing of the Registrant's annual
report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where
applicable, each filing of an employee benefit plan's annual report pursuant to
Section 15(d) of the Exchange Act) that is incorporated by reference in this
Registration Statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Act may be
permitted to directors, officers and controlling persons of the Registrant
pursuant to the provisions described in Item 6 above, or otherwise, the
Registrant has been advised that in the opinion of the Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
II-4
<PAGE> 7
REOFFER PROSPECTUS
HEALTH MANAGEMENT SYSTEMS, INC.
401 PARK AVENUE SOUTH
NEW YORK, NEW YORK 10016
(212)685-4545
637,001 Shares
Health Management Systems, Inc.
Our Common Stock is listed on the Nasdaq-Amex National Market System under
the symbol "HMSY". The reported last sale price of the Common Stock on the
Nasdaq-Amex National Market System on April 19, 1999, was $4.44 per share.
These shares of Common Stock may be issued to our officers, directors and
employees when they exercise stock options and other awards granted to them
under our Long-Term Incentive Stock Plan and our prior Stock Option and
Restricted Stock Purchase Plan. These shareholders may then sell these shares in
the open market or otherwise. We will not receive any part of the proceeds from
these sales.
The shares have not been approved by the SEC or any state securities
commission, nor have these organizations determined that this prospectus is
accurate or complete. Any representation to the contrary is a criminal offense.
The date of this Prospectus is April 27, 1999
<PAGE> 8
TABLE OF CONTENTS
Where You Can Find More Information.....................................1
About Health Management Systems, Inc. ("HMS")...........................2
Potential Future Selling Shareholders...................................4
Plan of Distribution....................................................5
Validity of the Shares..................................................5
Experts.................................................................5
Other Matters...........................................................6
<PAGE> 9
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements and
other information with the SEC. You may read and copy any document we file at
the SEC's public reference rooms in Washington, D.C., New York, New York and
Chicago, Illinois. Please call the SEC at 1-800-SEC-0330 for further information
on the public reference rooms. Our SEC filings are also available to the public
from our web site at www.hmsy.com or at the SEC's web site at www.sec.gov.
The SEC allows us to "incorporate by reference" the information we
file with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference is
considered to be part of this prospectus, and later information that we file
with the SEC will automatically update and supersede this information. We
incorporate by reference the documents listed below and any future filings made
with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange
Act of 1934 until the Potential Future Selling Shareholders sell all the shares
covered by this prospectus. This prospectus is part of a registration statement
we filed with the SEC (Registration No. 333-77121).
We are incorporating the following documents by reference:
Annual Report on Form 10-K for the year ended October 31, 1998; and
Quarterly Report on Form 10-Q for the quarter ended January 31, 1999.
You may request a copy of these filings, at no cost, by writing or
telephoning us at the following address:
Shareholder Services
Health Management Systems, Inc.
401 Park Avenue South
New York, New York 10016
(212)685-4545
You should rely only on the information incorporated by reference or
provided in this prospectus or any supplement. We have not authorized anyone
else to provide you with different information. The Potential Future Selling
Shareholders will not make an offer of these shares in any state where the offer
is not permitted. You should not assume that the information in this prospectus
or any supplement
1
<PAGE> 10
is accurate as of any date other than the date on the front of those documents.
ABOUT HMS
HMS furnishes proprietary information management and data processing
products and services to healthcare providers and payors, including government
health service agencies. These services address the various types of data
generated by the interaction of the participants in the healthcare delivery
process: the providers of care, the third-party payors, and the patients.
Through its product and service offerings, the Company acts as an outsourcer of
information management functions addressing the operational, administrative,
financial, and clinical data that result from the rendering of healthcare
services to patients. The Company's product and service offerings benefit its
clients by enhancing revenue (achieved through improved reimbursability,
profitability, and/or collectability), accelerating cash flow, reducing
operating and administrative costs (by supplying advanced information
analytics), and improving decision-making capabilities (via the provision of
useful information).
Healthcare providers receive payment for services from patients,
third-party payors, or a combination thereof. Third-party payors include
commercial insurance companies, governments or their fiscal agents and
intermediaries, health maintenance organizations, preferred provider
organizations, third-party administrators for self-insured companies, and
managed care companies. Although patients generally retain primary
responsibility for payment for all healthcare services, third-party payors bear
the preponderance of the responsibility for many charges for care. Obtaining
reimbursement from third-party payors has become increasingly difficult because
of frequent changes in reimbursement formulae and contractual requirements for
pre-admission certification and utilization review, and administrative
procedures instituted by third-party payors in an effort to control costs. To be
successful in obtaining payment from third-party payors, hospitals and other
healthcare providers require regulatory knowledge and technical skills to manage
complex data collection, integration, analysis, and accounts receivable
management functions. To ensure that program costs are not greater than
necessary, third-party payors require knowledge and skills analogous to those
required by providers.
2
<PAGE> 11
Using the operational, financial, administrative, and clinical data
generated as part of the healthcare delivery process, the Company applies
proprietary software and other analytical tools to transform data into valuable
information that clients use to (i) minimize operating and administrative costs
while improving profitability, (ii) measure the quality of care, and (iii)
optimize the outcome of the transfer payment processes linking payors,
providers, and patients. Customers of the Company utilize the Company's products
and services to improve their decision-making and operating capabilities and to
achieve improved operational, administrative, financial, and clinical
performance. The Company believes its customers benefit from the Company's
unique understanding of the healthcare delivery and associated transfer payment
processes, from the perspective of both providers and payors.
3
<PAGE> 12
POTENTIAL FUTURE SELLING SHAREHOLDERS
The executive officers and directors listed in the table below are
labeled "Potential Future Selling Shareholders" for purposes of this Prospectus
only. It does not imply that all of these individuals currently intend to
exercise and hold or sell. Rather, the table is provided to illustrate the
potential effect that could result if any of the individuals listed herein as
of April 19, 1999 were to sell their portion of the 637,001 shares of Common
Stock that would be owned as a result of their exercise of any vested stock
options through the end of the Company's fiscal year ending October 31, 1999.
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------------------------------------
NUMBER OF
NUMBER OF PERCENT OF NUMBER OF SHARES TO BE
SHARES OWNED CLASS OWNED SHARES OFFERED OWNED AFTER PERCENT OF
NAME PRIOR TO OFFERING PRIOR TO HEREBY COMPLETION OF CLASS OWNED
OFFERING OFFERING(1) AFTER OFFERING(1)
- ---------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Paul J. Kerz 1,079,317 6.1% 299,019 780,298 4.4%
Robert V. Nagelhout 269,785 1.5% 64,916 204,869 1.2%
Alan L. Bendes 21,000 * 21,000 0 *
Donald J. Staffa 200,872 1.1% 148,155 52,717 *
Thomas J. Kazamek 210,762 1.2% 78,713 132,049 *
Lewis D. Levetown 10,738 * 3,000 7,738 *
Randolph G. Brown 3,250 * 2,500 750 *
William W. Neal 40,171 * 2,500 37,671 *
Galen D. Powers 17,685 * 12,198 5,487 *
Ellen A. Rudnick 7,000 * 2,500 4,500 *
Richard H. Stowe 64,114 * 2,500 61,614 *
- ---------------------------------------------------------------------------------------------------------------------------------
</TABLE>
- ----------
* denotes percentage of ownership is less than 1%
(1) For illustration purposes, required calculations are shown as if sales
of the shares that could be acquired from exercise of vested options
through October 31, 1999 would have happened.
4
<PAGE> 13
PLAN OF DISTRIBUTION
The Potential Future Selling Shareholders may, from time to time, offer
all or part of the shares acquired by them pursuant to awards on the
over-the-counter market or such national securities exchange upon which the
Common Stock is traded at the time of such sales, at prices prevailing at the
time of such sales, or in negotiated transactions. Potential Future Selling
Shareholders may also pledge their shares to banks, brokers or other financial
institutions as security for margin loans or other financial accommodations that
may be extended to such Potential Future Selling Shareholders, and any such
pledgee institution may similarly offer, sell and effect transactions in such
shares. The Company will pay all expenses in preparing and reproducing the
Registration Statement of which this Prospectus is a part, but will not receive
any part of the proceeds of any sales of such shares. In addition, any
securities covered by this Prospectus which qualify for sale pursuant to Rule
144 under the Act may be sold under Rule 144 rather than pursuant to this
Prospectus. Should sales by the Potential Future Selling Shareholders occur,
they will pay their own brokerage commissions. Each Potential Future Selling
Shareholder (and pledgee) reserves the sole right to accept and, together with
its agents from time to time, to reject, in whole or in part, any proposed
purchase of shares to be made directly or through agents.
The Company and the Potential Future Selling Shareholders may enter
into customary agreements concerning indemnification and the provision of
information in connection with the sale of their shares of Common Stock.
VALIDITY OF THE SHARES
The validity of the shares of Common Stock offered hereby will be
passed upon for the Company by Coleman, Rhine & Goodwin LLP, 750 Lexington
Avenue, New York, New York 10022. Partners of Coleman, Rhine & Goodwin LLP own
6,762 shares of Common Stock.
EXPERTS
The consolidated financial statements and financial statement schedule
of the Company as of October 31, 1998 and 1997, and for each of the years in the
three-year period ended October 31, 1998, have been incorporated by reference
herein and in the Registration Statement in reliance upon the report of KPMG
LLP, independent certified public accountants, incorporated by reference herein,
and upon the authority of said firm as experts in accounting and auditing.
5
<PAGE> 14
OTHER MATTERS
The Business Corporation Law of the State of New York provides that,
under certain circumstances, directors, officers, employees or agents of a New
York corporation may be indemnified against expenses, payments, fines and
amounts actually and reasonably incurred by them in connection with settling, or
otherwise disposing of, suits or threatened suits, to which they are a party or
threatened to be named a party by reason of acting in any of such capacities, if
such person acted in good faith and in a manner such person reasonably believed
to be in, or not opposed to, the best interests of the corporation. The by-laws
of the Company provide for indemnification of officers and directors under the
circumstances, and to the extent, permitted by law. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors,
officers or persons controlling the Company pursuant to the foregoing provisions
and agreements, the Company has been informed that, in the opinion of the
Commission, such indemnification is against public policy as expressed in such
Securities Act and is therefore unenforceable.
6
<PAGE> 15
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this Post-
Effective Amendment No. 1 to Registration Statement on Form S-8 to be signed on
its behalf by the undersigned, thereto duly authorized, in the City of New
York, State of New York, on May 10, 1999.
HEALTH MANAGEMENT SYSTEMS, INC.
By: /s/ Paul J. Kerz
-------------------------------------
Paul J. Kerz
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed by
the following persons in the capacities indicated below on the respective dates
set forth below.
<TABLE>
<S> <C> <C>
/s/ Paul J. Kerz Chairman, President, Chief Executive Officer May 10, 1999
- ---------------------------- and Director
Paul J. Kerz
*/s/ Robert V. Nagelhout Executive Vice President, Chief Operating May 10, 1999
- ---------------------------- Officer and Director
Robert V. Nagelhout
/s/ Alan L. Bendes Senior Vice President and Chief Financial and May 10, 1999
- ---------------------------- Accounting Officer
Alan L. Bendes
*/s/ Donald J. Staffa Senior Vice President and Director May 10, 1999
- ----------------------------
Donald J. Staffa
*/s/ Randolph G. Brown Director May 10, 1999
- ----------------------------
Randolph G. Brown
*/s/ William W. Neal Director May 10, 1999
- ----------------------------
William W. Neal
*/s/ Galen D. Powers Director May 10, 1999
- ----------------------------
Galen D. Powers
*/s/ Ellen A. Rudnick Director May 10, 1999
- ----------------------------
Ellen A. Rudnick
*/s/ Richard H. Stowe Director May 10, 1999
- ----------------------------
Richard H. Stowe
*By: /s/ Alan L. Bendes May 10, 1999
-----------------------
Alan L Bendes
as Attorney-in-fact
</TABLE>
II-5
<PAGE> 16
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
+4 Health Management Systems, Inc. 1999 Long-Term
Incentive Stock.
+5 Opinion of Coleman, Rhine & Goodwin LLP with
respect to the legality of the securities being
registered.
+23.1 Consent of Coleman, Rhine & Goodwin LLP (included
in Exhibit 5).
23.2 Consent of KPMG LLP.
+24 Powers of Attorney.
___________
+ Previously filed
<PAGE> 1
Exhibit 23.2
Accountants' Consent
Board of Directors
Health Management Systems, Inc.
We consent to the use of our report incorporated by reference and to the
reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP
New York, New York
May 10, 1999
